Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients With Moderate to Severe Ulcerative Colitis
vedolizumab
C13006
NCT00783718
2008-002782-32
Ulcerative Colitis; Crohn's Disease
Phase 3
 
October 2014

Powered by ideaPoint, Inc.